Physician profile
Taylor Howdon
NPI 1437614898
$1,118.46
in general payments reported to CMS, 2019-2025
13 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $887 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $379.46 | 2024-2025 | Repatha, Repatha |
| Abiomed | $169.19 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.26 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $110.35 | 2024 | Xarelto |
| Novo Nordisk INC | $63.35 | 2024 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals International, Plc | $61.02 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $44.70 | 2024 | Flexitouch Plus, Entre Plus |
| Boston Scientific Corporation | $33.59 | 2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $31.39 | 2024 | |
| Recor Medical INC | $25.54 | 2024 | Paradise Renal Denervation System |
| Astrazeneca Pharmaceuticals LP | $20.79 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $19.87 | 2024 | |
| Sanofi-Aventis U.S. LLC | $18.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Howdon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.